Global organ preservation market value is estimated to reach USD 455 Million by 2032, with a compound annual growth rate of 6.4%.
The process of preserving healthy organs from a donor so that they can be transplanted into the body of a recipient is called organ preservation. Static cold storage (SCS) aids in maintaining normal organ function after transplantation by preventing harmful metabolites from degrading healthy tissue.
Those suffering from terminal diseases are the most likely to benefit from organ transplantation. Preservation solutions and techniques are essential to preserving organ quality and preventing transplant-associated death and morbidity. In most cases, static cold storage (SCS) is considered to be the most efficient and effective method of preserving and transporting organs due to its simplicity and effectiveness.
Over the past few decades, solid organ transplants have been one of the most significant medical advancements. A wide variety of methods for preserving organs have been applied during cold storage to reduce ischemic and hypoxic injury and increase graft survival.
Since the advent of clinical organ transplants 50 years ago, patient and graft survival rates have surpassed 90% per year, resulting in organ transplantation becoming the treatment of choice for end-stage organ disease patients.
| Attributes | Details |
|---|---|
| Organ Preservation Market CAGR (2022 to 2032) | 6.4% |
| Organ Preservation Market (2026) | USD 317 Million |
| Organ Preservation Market Attraction | A rising proportion of the geriatric population in North America and European countries will be the major driver for the growth of the global organ preservation market during the forecasted years. |
With the largest population seeking better treatments, including organ transplantation preservation, the Asia Pacific region is expected to be the fastest-growing region as a whole in the industry. Asian countries are seeing an increase in awareness about organ donation, which has led to a rise in the market for organ preservation solutions.
Developing nations such as India and China are experiencing an increase in eye, cardiac, and kidney diseases. Technology advancement and emerging markets will offer profitable opportunities for the market. The government has also taken several initiatives to promote organ donation as part of its efforts to further expand the market growth. For instance,
Organ donation and transplantation are promoted by the Indian government through its National Organ Transplant Programme (NOTP). Several regional and state organ and tissue transplant organizations have been established under this initiative: one at the highest level in New Delhi, five at the regional level, and sixteen at the state level.
The National Organ Transplant Programme provides financial assistance to States for the establishment of Biomaterial Centers. Various IEC activities are being organized to raise public awareness and impart training to physicians and transplant coordinators to facilitate the acceptance of transplants.
With targeted radiotherapy and chemotherapy, medical professionals aim to preserve a surgically removed organ by preventing the particular cell from multiplying as a result of targeting radiotherapy and chemotherapy. As part of UICC's Access to Oncology Medicines (ATOM) initiative, multiple stakeholders were invited to the table to find ways of making cancer medicines more accessible and affordable especially in India.
An exciting development in health care has been the development of xenotransplantation - the ability to use a genetically modified organ from an animal to be used in humans after genetic modification. As gene editing techniques are developed and new knowledge is gained about the immunology of animals and its differences from the immune system of humans, it will probably continue to be a field that sees many advancements in the near future.
The geriatric population count is increasing day by day, leading to increased incidents of multi-organ failures and organ transplant surgeries worldwide. The requirement for efficient management of organ transfer from donors is driving the organ preservation market.
In 2019, the Health Resources and Services Administration reported about a rise in death cases due to multiple organ failures in the USA. The major treatment for such types of patients is organ replacement facilitated by human organ transplantation surgeries.
The organs obtained from donors require the appropriate handling and care achieved through the proper organ storage in cryogenic systems. The companies providing organic preservation solutions to hold and carry organs from donors to patients have experienced exponential growth these days.
Organ procurement and transplant network have expanded many folds making it easier for patients suffering from organ disorders. Organ preservation chemicals used for the storage of such organs obtained from companies dealing in the medical sector have benefitted immensely in recent years.
Diabetes and Chronic diseases have increased in frequency in the recent past resulting in severe medical conditions for multiple organ failures. Cardiovascular disorders and obesity have escalated the condition of patients to undertake the replacement of organs providing a huge impetus for the growth of the organ preservation market across the globe.
Solid-Organ transplant procedures have become more successful and safer in the 21st century owing to considerable advancement in surgical procedures and knowledge about the function of different organs.
But the healthcare sector is still struggling to meet the demands for organ transplantation due to the unavailability of sufficient organ donors or the limited supply of organ preservation fluids required to store and transport the organs already donated.
What are the Recent Developments Providing Better Opportunities for the Growth of the Organ Preservation Market?
Over the past years, there have been some major advancements in medical science, particularly in the field of organ preservation techniques and transplantation procedures, creating a huge demand for organ transplants in the global market. Coupled with the rising burden of diabetes patients, the demand for static cold storage organ preservation requirements during these years.
Encouragement for organ donations by various national and international NGOs has spurred the demand for organ preservation chemicals in the lesser-known regions of the world.
Improving health infrastructure across all countries has resulted in increased cases of patient termination in healthcare and medical facilities. The growing supply of organ preservation solutions in such major institutions has made it easier for the collection and preservation of human organs to be utilized by the organ preservation market.
What are Some of the Major Challenges faced by the Global Organ Preservation Market Players in Different Regions?
The development of cryogenic facilities for the maintenance of organ preservation fluid quality during transportation is a major challenge for the global organ preservation market, particularly in developing countries of the Asia Pacific and the Middle East and Africa (MEA).
The cost incurred during organ transplant surgeries and higher expenditure on inpatient care provided by healthcare facilities has remained the major constraint for the growth of the organ preservation and transplantation market. Patients in low-income countries require low-budget healthcare facilities to contribute more to the organ preservation market.
What are the Limitations in the Adoption of Organ Preservation Techniques in Recent Periods?
Availability of skilled personnel or surgery doctors at the healthcare centers is pride predicted to be the major challenge for the growth of the organ preservation and transplantation market during the forecast period at a higher scale.
Availability of suitable donors can be another major hindrance in the development of organ preservation techniques reducing the investment in research and advancement of organ preservation procedures by government institutions and private firms.
The most adopted technique is the static cold storage organ preservation method, commonly referred to as the gold standard technique of Organ preservation. This technique is very convenient to reduce metabolic activities and increase the self-life of the organs. This technique is popular for lung, heart, pancreas, and kidney preservation.
Hypothermia Machine Perfusion and Normothermic Machine Perfusion are some of the other techniques that need some research and technological advancements to compete with the static cold storage technique segment.
By the previous market analysis report, kidney preservation was the segment holding the largest share of the global organ preservation market. The escalating cases of ESRD with kidney transplantation have emerged as the major driver for this segment of the market and are predicted to be leading in the forthcoming years.
The other segment based on organ type having the highest potential of growth is liver preservation during the forecast period of 2022 to 2032. Lung, heart, and pancreas preservation are the other segments contributing to the growing trend of organ preservation.
By 2021, organ transplant centers were the dominating end users of the organ preservation market providing kidney preservation and liver preservation in different regions of the world. The better healthcare facilities and the increasing success rate has made it a popular choice for patients seeking organ replacement around the world. This segment is expected to remain at the forefront of organ preservation and transplantation during the forecast years.
Hospitals and other end users will also contribute significantly to the global organ preservation market, as per the report of the market analysis.
North America, comprising a higher proportion of the elder population and advanced Healthcare facilities, is poised to remain the most attractive region for organ storage and transplantation services.
The rising demand for technologically advanced treatment methods, government support, and reimbursements have fuelled the market for preserved human organs in recent times.
As per the report provided by the American Heart Association and National Chronic Kidney Disease Report, 31% of the total deaths in the USA occurred due to cardiovascular disorders in 2014 and in 2017, 15% of USA adults were subject to chronic kidney diseases.
Due to rising cases of alcoholic fatty liver diseases, Liver failures have positioned the Europe region as the second-largest market for organ preservation and transplantation, following North America. The healthcare expenditure in European countries has further fuelled the market for lever preservation for transplant facilities.
The prevalence of other serious diseases related to cardiovascular and renal will further supplement the demand for organ transplantation surgeries in this region.
Asia Pacific region is predicted to be the fastest-growing region for having the largest population count seeking better treatment methods, including organ transplantation preservation
services. The rising awareness about organ donations has boosted the organ preservation solution market in Asian countries.
Lack of awareness and affordability constraints for organ preservation techniques could render the Middle East and African countries the least attractive region for the global organ preservation market in the coming years.
The key players in the organ preservation driving the global market are XVIVO Perfusion AB, Dr. Franz Kohler Chemie GmbH, Essential Pharmaceuticals LLC, Trans Medics, Organ Ox Limited, Shanghai Genext Medical Technology, Bridge to Life Limited, Waters Medical Systems, Preservation Solutions, Carnamedica, and Transplant Biomedicals.
All the prominent players dealing in organ preservation have continually adopted the advancing technologies and have changed the course of organ preservation from the past to the future to provide the best service for patients in need.
In recent years they have been focusing on mergers and collaboration to expand the customer base in traditionally less popular regions.
Some of the Recent Developments in the Organ Preservation Market:
The global organ preservation market is predicted to register a CAGR of 6.4% during the forecast period.
The global organ preservation market was valued at USD 230 Million in 2021.
The global organ preservation market is predicted to become a USD 317 Million market by the year 2026.
The total market value of the organ preservation market is estimated to reach a value of about USD 455 Million by the end of 2032.
North America is the dominant region that captured a major share of the global organ transplant preservation market and is predicted to remain in the leading position for some more years ahead.
Explore Medical Supplies Insights
Organ Preservation Market
Thank you!
You will receive an email from our Business Development Manager. Please be sure to check your SPAM/JUNK folder too.
